Antiproliferative effect of synthetic resveratrol on human breast epithelial cells

International Journal of Oncology

Volumn 12, Issue 4, 1998, Pages 865-869

  Mgbonyebi, Ozuem P ^a   Russo, Jose ^a   Russo, Irma H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Cell proliferation; Chemoprevention; Resveratrol

Indexed keywords

ESTROGEN RECEPTOR; PHYTOALEXIN; RESVERATROL;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031891466     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.4.865     Document Type: Article

References (34)

1. Pitot HC and Dragan YP: Facts and theories concerning the mechanism of carcinogenesis. FASEB J 5: 2280-2286, 1991.
2. Harris CC: Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res 51 (Suppl.): 5023s-5044s, 1991.
3. Weinstein IB: The origins of human cancer: Molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment - Twenty-seventh G.H.A. Clowes Memorial Award Lecture. Cancer Res 48: 4135-4143, 1988.
4. Pitot HC: The molecular biology of carcinogenesis. Cancer 72: 962-970, 1993.
5. Weinstein IB: Current concepls and controversies in chemical carcinogenesis. Supramol Struct Cell Biochem 17: 99-120, 1981.
6. Schwab M and Amier LC: Amplificalion of cellular oncogenes: a predictor of clinical outcome in cancer. Cancer 1: 181-193, 1990.
7. Sporn MB: The war on cancer. Lancet 347: 1377-1381, 1996.
8. El-Bayoumy K: Evaluation of chemoprevenlive agents against breast cancer and proposed strategies for future clinical intervention trials. Carcinogenesis 15: 2395-2420, 1994.
9. Fabian CJ and Kimler BF: Chemoprevention of breast cancer. Breast J 5: 220-226, 1997.
10. Block G, Patterson B and Subar A: Fruits, vegetables and cancer prevention. A review of the epidemiological evidence. Nutr Cancer 18: 1-29, 1992.
11. Negri E, Ia Vecchia C, Franceschi S, D'Avenzo B and Parazzini F: Vegetable and fruit consumption and cancer risk. Int J Cancer 48: 350-354, 1991.
12. Wattenberg LW: Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 52 (Suppl.): 2085s-2091s, 1992.
13. Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet RL, Doody LA and Greenwald P: Development of breast cancer chemopreventive drugs. J Cell Biochem 17G: 2-13, 1993.
14. Goldberg DM: Does wine work? Clin Chem 41: 14-16, 1995.
15. Jang MJ, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RJ, Moon RC and Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
16. Soule HD, Vazquez J, Long A, Albert S and Brennan MJ: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1412, 1973.
17. Brooks SC, Locke ER and Soule HD: Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 248: 6251-6253, 1973.
18. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF and Brooks SC: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086, 1990.
19. Tait L, Soule H and Russo J: Utrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line MCF-10. Cancer Res 50: 6087-6099, 1990.
20. Zhou J-N and Linder S: Expression of CDK inhibitor in immortalized and carcinoma derived breast cell lines. Anticancer Res 16: 1931-1936, 1996.
21. Graham S, Dayal H, Swanson M, Mittelman A and Wilkinson G: Diet in the epidemiology of colon and rectum. J Natl Cancer Inst 51: 708-714, 1978.
22. Philips RL: Role of lifestyle and dietary habits among Seventh-Day Adventists. Cancer Res 35: 3513-3522, 1975.
23. Correa P: Epidemiological correlations between diet and cancer frequency. Cancer Res 41: 3685-3690, 1981.
24. Pezzuto JM: Plant-derived anticancer agents. Biochem Pharm 53: 121-133, 1997.
25. Lepley DM, Li B, Birt DF and Polling JC: The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 17: 2367-2375, 1996.
26. Fahey JW, Zhang Y and Talay P: Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect asainst chemical carcinogenesis. Proc Natl Acad Sci USA 94: 10367-10372, 1997.
27. Mehta RG, Lui J, Constantinou A, Thomas CF, Hawthorne M, Gerhauser C, Pezzuto JM, Moon RC and Moriarty RM: Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis 16: 399-404, 1995.
28. Uenobe F, Nakamura S and Miyazawa M: Antimutagenic effect of resveratrol against Trp-P-1. Mutat Res 373: 197-200, 1997.
29. Hickman JA: Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11: 121-139, 1992.
30. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542, 1994.
31. Alaoui SE, Lawry J and Griffin M: The cell cycle and induction of apoptosis in fibrosarcoma cell line treated with anti-cancer drugs: its importance to solid tumor chemotherapy. J Neuro-Oncol 31: 195-207, 1997.
32. Muller M, Strand S, Hug H, Heinemann E, Walczak H, Hoffmann WJ, Stremmel W, Krammer PH and Galle PR: Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system involves activation of wildtype p53. J Clin Invest 99: 403-413, 1997.
33. Williams JT: Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097-1098, 1991.
34. Su N, Luyengi L, Fong HSS, Kinghorn AD and Pezzuto JM: Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model. Anticancer Res 15: 233-240, 1995.